CGM Use in Pregnancy Improves Neonatal Outcomes

This article originally appeared here.
Share this content:
CGM Use in Pregnancy Improves Neonatal Outcomes
CGM Use in Pregnancy Improves Neonatal Outcomes

MONDAY, Sept. 18, 2017 (HealthDay News) -- For pregnant women with type 1 diabetes, use of continuous glucose monitoring (CGM) is associated with improved neonatal outcomes, according to a study published online Sept. 15 in The Lancet to coincide with the annual meeting of the European Association for the Study of Diabetes, held from Sept. 11 to 15 in Lisbon, Portugal.

Denice S. Feig, M.D., from the Sinai Health System in Toronto, and colleagues randomized women aged 18 to 40 years with type 1 diabetes for a minimum of 12 months who were receiving intensive insulin therapy to receive CGM in addition to capillary glucose monitoring (108 pregnant women, 53 planning pregnancy) or capillary glucose monitoring alone (107 pregnant women, 57 planning pregnancy).

The researchers observed a small, but significant, difference in hemoglobin A1c in pregnant women using CGM (mean difference, −0.19 percent). Compared with controls, pregnant women with CGM spent more time in target and less time hyperglycemic. Significant improvements were seen in neonatal health outcomes, with lower incidence of large for gestational age (odds ratio, 0.51), fewer neonatal intensive care admissions lasting more than 24 hours and incidences of neonatal hypoglycemia (odds ratios, 0.48 and 0.45, respectively), and one-day shorter length of hospital stay. For women planning pregnancy, there was no apparent benefit for CGM.

"Use of CGM during pregnancy in patients with type 1 diabetes is associated with improved neonatal outcomes," the authors write.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

USPSTF Urges Abuse Screening for Reproductive-Aged Women

USPSTF Urges Abuse Screening for Reproductive-Aged Women

Evidence lacking for assessing balance of benefits, harms of screening for abuse of seniors, vulnerable

Five-Day Nitrofurantoin Beats Single-Dose Fosfomycin for UTI

Five-Day Nitrofurantoin Beats Single-Dose Fosfomycin for UTI

Increased likelihood of clinical and microbiological resolution for uncomplicated UTI in women

Exercise Intervention Doesn't Improve Walking Ability in PAD

Exercise Intervention Doesn't Improve Walking Ability in PAD

Smaller mean change from baseline to follow-up in 6-minute walking distance with exercise intervention

is free, fast, and customized just for you!

Already a member?

Sign In Now »